Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $16.0K | $56.3K | $19.0K |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $8.0K | $25.7K | $130.5K |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $8.0K | $30.6K | −$112.0K |
| Gross margin | — | — | — | — | — | 50.0% | 54.3% | -590.8% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$284.0K | −$80.4K | −$111.0K | −$103.0K | −$662.0K | −$2.6M | −$4.1M | −$1.7M |
| EBITDA | −$284.0K | −$80.4K | −$111.0K | −$103.0K | −$608.0K | −$2.9M | −$193.0K | −$1.3M |
| Net income | −$263.0K | −$83.7K | −$112.0K | −$174.0K | −$3.3M | −$3.2M | −$4.4M | −$3.0M |
| Net margin | — | — | — | — | — | -19712.0% | -7844.2% | -15613.5% |
| EPS (diluted) | -0.01 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Annual figures · source: Financial Modeling Prep
NASS VY GATEWAY LTD
No one on the platform currently holds NSVGF.
No tracked institution reports a position in NSVGF as of their last filing.
No one on the platform has traded NSVGF yet.
| $5M |
| — |
| CNFHFCanaFarma Hemp Products Corp. | $0.00 | +0.00% | $19561 | — |
| INTIInhibitor Therapeutics, Inc. | $0.09 | +0.00% | $16M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.